Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹100 Cr₹92 Cr₹46 Cr₹-1.95 Cr₹-117 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹100 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹100 Cr
Mar2024₹92 Cr
Mar2023₹46 Cr
Mar2022₹-1.95 Cr
Mar2021₹-117 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹100 Cr
8.13
Mar2024 ₹92 Cr
98.99
Mar2023 ₹46 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-117 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,851.7 Cr 0.6% 14.7% 39% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

0.6%

14.7%

39%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses